Advertisement
Advances in Pediatrics

Pediatric Brain Tumors

      Brain tumors are the most common solid cancer of childhood and are currently the leading cause of death in children, excluding trauma [
      • Smith E.R.
      • Butler W.E.
      • Barker 2nd, F.G.
      Craniotomy for resection of pediatric brain tumors in the United States, 1988–2000: effects of provider caseloads and progressive centralization and specialization of care.
      ,
      • Surawicz T.S.
      • Davis F.
      • Freels S.
      • et al.
      Brain tumor survival: results from the National Cancer Data Base.
      ,
      • Surawicz T.S.
      • McCarthy B.J.
      • Kupelian V.
      • et al.
      Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994.
      ]. The number of primary and metastatic brain tumors is steadily increasing, whereas mortality rates for many central nervous system (CNS) tumor types have remained essentially unchanged [
      • Barker 2nd, F.G.
      • Curry Jr., W.T.
      • Carter B.S.
      Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.
      ]. Many of these tumors remain difficult to detect before the onset of symptoms. Once identified, rapid referral to an appropriate specialist for treatment is often critical to obtaining an optimal outcome.
      To read this article in full you will need to make a payment

      References

        • Smith E.R.
        • Butler W.E.
        • Barker 2nd, F.G.
        Craniotomy for resection of pediatric brain tumors in the United States, 1988–2000: effects of provider caseloads and progressive centralization and specialization of care.
        Neurosurgery. 2004; 54 ([discussion: 563–65]): 553-563
        • Surawicz T.S.
        • Davis F.
        • Freels S.
        • et al.
        Brain tumor survival: results from the National Cancer Data Base.
        J Neurooncol. 1998; 40: 151-160
        • Surawicz T.S.
        • McCarthy B.J.
        • Kupelian V.
        • et al.
        Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994.
        Neuro Oncol. 1999; 1: 14-25
        • Barker 2nd, F.G.
        • Curry Jr., W.T.
        • Carter B.S.
        Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care.
        Neuro Oncol. 2005; 7: 49-63
        • Farwell J.R.
        • Dohrmann G.J.
        • Flannery J.T.
        Intracranial neoplasms in infants.
        Arch Neurol. 1978; 35: 533-537
        • Fernandez C.A.
        • Yan L.
        • Louis G.
        • et al.
        The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients.
        Clin Cancer Res. 2005; 11: 5390-5395
        • Medina L.S.
        • Pinter J.D.
        • Zurakowski D.
        • et al.
        Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging.
        Radiology. 1997; 202: 819-824
        • Keles G.E.
        • Banerjee A.
        • Puri D.
        • et al.
        Supratentorial gliomas.
        in: Gupta N. Banerjee A. Haas-Kogan D. Pediatric CNS tumors. Springer, Berlin2004
        • Kim I.Y.
        • Niranjan A.
        • Kondziolka D.
        • et al.
        Gamma knife radiosurgery for treatment resistant choroid plexus papillomas.
        J Neurooncol. 2008; 90: 105-110
      1. Ries L.A.G. Eisner E.P. Kosary C.L. SEER Cancer Statistics Review, 1975–2000. National Cancer Institutue, Bethesda (MD)2003
        • Dohrmann G.J.
        • Farwell J.R.
        • Flannery J.T.
        Astrocytomas in childhood: a population-based study.
        Surg Neurol. 1985; 23: 64-68
        • Taylor T.
        • Jaspan T.
        • Milano G.
        • et al.
        • PLAN Study group
        Radiological classification of optic pathway gliomas: experience of a modified functional classification system.
        Br J Radiol. 2008; 81: 761-766
        • Binning M.J.
        • Liu J.K.
        • Kestle J.R.
        • et al.
        Optic pathway gliomas: a review.
        Neurosurg Focus. 2007; 23: E2
        • Mehta V.
        • Chapman A.
        • McNeely P.D.
        • et al.
        Latency between symptom onset and diagnosis of pediatric brain tumors: an Eastern Canadian geographic study.
        Neurosurgery. 2002; 51: 365-372
        • Pollack I.F.
        • Gerszten P.C.
        • Martinez A.J.
        • et al.
        Intracranial ependymomas of childhood: long-term outcome and prognostic factors.
        Neurosurgery. 1995; 37 ([discussion: 666–67]): 655-666
        • Packer R.J.
        • Sutton L.N.
        • Bilaniuk L.T.
        • et al.
        Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update.
        Ann Neurol. 1988; 23: 79-85
        • Bloom H.J.
        • Glees J.
        • Bell J.
        • et al.
        The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950–1981.
        Int J Radiat Oncol Biol Phys. 1990; 18: 723-745
        • Packer R.J.
        • Ater J.
        • Allen J.
        • et al.
        Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
        J Neurosurg. 1997; 86: 747-754
        • Gururangan S.
        • Cavazos C.M.
        • Ashley D.
        • et al.
        Phase II study of carboplatin in children with progressive low-grade gliomas.
        J Clin Oncol. 2002; 20: 2951-2958
        • Sposto R.
        • Ertel I.J.
        • Jenkin R.D.
        • et al.
        The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.
        J Neurooncol. 1989; 7: 165-177
        • Finlay J.L.
        • Boyett J.M.
        • Yates A.J.
        • et al.
        Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.
        J Clin Oncol. 1995; 13: 112-123
        • von Koch C.S.
        • Schmidt M.H.
        • Perry V.
        Neuronal tumors.
        in: Gupta N. Barnerjee A. Haas-Kogan D. Pediatric CNS tumors. Springer, Berlin2004 (p. 143–55)
        • Johannssen J.H.
        • Rekate H.L.
        • Roessmann U.
        Gangliogliomas: pathological and clinical correlation.
        J Neurosurg. 1981; 54: 58-63
        • Johnson Jr., J.H.
        • Hariharan S.
        • Berman J.
        • et al.
        Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years.
        Pediatr Neurosurg. 1997; : 203-207
        • Morris H.H.
        • Estes M.L.
        • Gilmore R.
        • et al.
        Chronic intractable epilepsy as the only symptom of primary brain tumor.
        Epilepsia. 1993; 34: 1038-1043
        • Wolf H.K.
        • Weister O.D.
        Surgical pathology of chronic epileptic seizure disorder.
        Brain Pathol. 1993; 3: 371-380
        • Hassoun J.
        • Soylemezoglu F.
        • Gambarelli D.
        • et al.
        Central neurocytoma: a synopsis of clinical and histological features.
        Brain Pathol. 1993; 3: 297-306
        • Osborn A.G.
        • Blazer S.
        • Saltzman K.
        Diagnostic imaging: brain.
        AMIRSYS, Salt Lake City (UT)2004
        • Benifla M.
        • Otsubo H.
        • Ochi A.
        • et al.
        Temporal lobe surgery for intractable epilepsy in children: an analysis of outcomes in 126 children.
        Neurosurgery. 2006; 59 ([discussion: 1213–14]): 1203-1213
        • Lieuw K.H.
        • Haas-Kogan D.
        • Ablin A.
        Intracranial germ cell tumors.
        in: Gupta N. Banerjee A. Haas-Kogan D. Pediatric CNS tumors. Springer, Berlin2004 (p. 107–21)
        • Wisoff J.H.
        • Donahue B.R.
        Craniopharyngiomas.
        in: Albright A.L. Pollack I. Adelson P.D. Principles and practice of pediatric neurosurgery. Thieme, New York2008
        • Du R.
        • Lustig R.H.
        • Fisch B.
        • et al.
        Craniopharyngioma.
        in: Gupta N. Barnerjee A. Haas-Kogan D. Pediatric CNS tumors. Springer, Berlin2004 (p. 132–42)
        • Ellenbogen R.G.
        • Winston K.R.
        • Kupsky W.J.
        Tumors of the choroid plexus in children.
        Neurosurgery. 1989; 25: 327-335
        • Moore K.
        • Couldwell W.T.
        Craniopharyngioma.
        in: Bernstein M. Berger M.S. Neuro-oncology: the essentials. Thieme, New York2000 (p. 409–18)
        • Taylor M.D.
        • Sanford R.A.
        • Boop F.A.
        Cerebellar pilocytic astrocytomas.
        in: Albright A.L. Pollack I. Adelson P.D. Principles and practice of pediatric neurosurgery. 2nd edition. Thieme, New York2008 (p. 655–67)
        • Burkhard C.
        • Di Patre P.L.
        • Schüler D.
        • et al.
        A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma.
        J Neurosurg. 2003; 98: 1170-1174
        • Chi J.H.
        • Gupta N.
        Cerebellar astrocytomas.
        in: Gupta N. Banerjee A. Haas-Koogan D. Pediatric CNS tumors. Springer, Berlin2004 (p. 27–47)
        • Fisher P.G.
        • Tihan T.
        • Goldthwaite P.T.
        • et al.
        Outcome analysis of childhood low-grade astrocytomas.
        Pediatr Blood Cancer. 2008; 51: 245-250
        • Pan E.
        • Prados M.
        Brainstem gliomas.
        in: Gupta N. Barnerjee A. Haas-Kogan D. Pediatric CNS tumors. Springer, Berlin2004 (p. 29–43)
        • Jallo G.I.
        • Biser-Rohrbaugh A.
        • Freed D.
        Brainstem gliomas.
        Childs Nerv Syst. 2004; 20: 143-153
        • Farmer J.P.
        • Montes J.L.
        • Freeman C.R.
        • et al.
        Brainstem gliomas. A 10-year institutional review.
        Pediatr Neurosurg. 2001; 34: 206-214
        • Farmer J.P.
        • McNeely P.D.
        • Freeman C.R.
        Brainstem Gliomas.
        in: Albright A.L. Pollack I. Adelson P.D. Principles and practice of pediatric neurosurgery. 2nd edition. Thieme, New York2008 (p. 640–54)
        • Horn B.N.
        • Smyth M.
        Ependymoma.
        in: Gupta N. Barnerjee A. Haas-Kogan D. Pediatric CNS tumors. Springer, Berlin2004 (p. 65–81)
        • Grill J.
        • Renaux V.K.
        • Bulteau C.
        • et al.
        Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.
        Int J Radiat Oncol Biol Phys. 1999; 45: 137-145
        • Fisher P.G.
        Embryonal tumors.
        in: Gupta N. Banerjee A. Haas-Kogan D. Pediatric CNS tumors. Springer, Berlin2004 (p. 83–105)
        • Packer R.J.
        • Rood B.R.
        • MacDonald T.J.
        Medulloblastoma: present concepts of stratification into risk groups.
        Pediatr Neurosurg. 2003; 39: 60-67
        • Horska A.
        • Ulug A.M.
        • Melhem E.R.
        • et al.
        Proton magnetic resonance spectroscopy of choroid plexus tumors in children.
        J Magn Reson Imaging. 2001; 14: 78-82
        • Humphreys R.P.
        • Nemoto S.
        • Hendrick E.B.
        • et al.
        Childhood choroid plexus tumors.
        Concepts Pediatr Neurosurg. 1987; 7: 1-18
        • Davies N.P.
        • Wilson M.
        • Harris L.M.
        • et al.
        Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS.
        NMR Biomed. 2008; 21: 908-918
        • Sutherland G.R.
        • Latour I.
        • Greer A.D.
        • et al.
        An image-guided magnetic resonance-compatible surgical robot.
        Neurosurgery. 2008; 62 ([discussion: 292–93]): 286-292
        • Bergers G.
        • Brekken R.
        • McMahon G.
        • et al.
        Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.
        Nat Cell Biol. 2000; 2: 737-744
        • Fang J.
        • Shing Y.
        • Wiederschain D.
        • et al.
        Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.
        Proc Natl Acad Sci U S A. 2000; 97: 3884-3889
        • Moses M.A.
        • Sudhalter J.
        • Langer R.
        Identification of an inhibitor of neovascularization from cartilage.
        Science. 1990; 248: 1408-1410
        • Beliveau R.
        • Delbecchi L.
        • Beaulieu E.
        • et al.
        Expression of matrix metalloproteinases and their inhibitors in human brain tumors.
        Ann NY Acad Sci. 1999; : 236-239
        • Kunishio K.
        • Okada M.
        • Matsumoto Y.
        • et al.
        Matrix metalloproteinase-2 and -9 expression in astrocytic tumors.
        Brain Tumor Pathol. 2003; 20: 39-45
        • Lampert K.
        • Machein U.
        • Machein M.R.
        • et al.
        Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors.
        Am J Pathol. 1998; 153: 429-437
        • Laurence K.M.
        The biology of choroid plexus papilloma in infancy and childhood.
        Acta Neurochir (Wien). 1979; 50: 79-90
        • Lena G.
        • Genitori L.
        • Molina J.
        • et al.
        Choroid plexus tumours in children. Review of 24 cases.
        Acta Neurochir (Wien). 1990; 106: 68-72
        • Noha M.
        • Yoshida D.
        • Watanabe K.
        • et al.
        Suppression of cell invasion on human malignant glioma cell lines by a novel matrix-metalloproteinase inhibitor SI–27: in vitro study.
        J Neurooncol. 2000; 48: 217-223
        • Paek S.H.
        • Kim D.G.
        • Park C.K.
        • et al.
        The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas.
        Oncol Rep. 2006; 16: 49-56
        • Park C.M.
        • Park M.J.
        • Kwak H.J.
        • et al.
        Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-Kinase/Akt signaling pathways.
        Cancer Res. 2006; 66: 8511-8519
        • Pollack I.
        Supratentorial hemispheric gliomas.
        in: Albright A.L. Pollack I. Adelson P.D. Principles and practice of pediatric neurosurgery. 2nd edition. Thieme, New York2008 (p. 511–30)
        • Thier M.
        • Roeb E.
        • Breuer B.
        • et al.
        Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate.
        Cancer Lett. 2000; 149: 163-170
        • Zhao J.X.
        • Yang L.P.
        • Wang Y.F.
        • et al.
        Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
        Eur J Neurol. 2007; 14: 510-516
        • Chan L.W.
        • Moses M.A.
        • Goley E.
        • et al.
        Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy.
        J Clin Oncol. 2004; 22: 499-506
        • Moses M.A.
        • Wiederschain D.
        • Loughlin K.R.
        • et al.
        Increased incidence of matrix metalloproteinases in urine of cancer patients.
        Cancer Res. 1998; 58: 1395-1399
        • Roy R.
        • Wewer U.M.
        • Zurakowski D.
        • et al.
        ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage.
        J Biol Chem. 2004; 279: 51323-51330
        • Yan L.
        • Borregaard N.
        • Kjeldsen L.
        • et al.
        The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL.
        J Biol Chem. 2001; 276: 37258-37265